The clinical candidate P218 has demonstrated that . PfDHFR was a historical target for antimalarials . It has been considered compromised by resistance inducing mutations caused by pyrimethamine (PYR) overexposure .
Discovery Of Rigid Biphenyl Plasmodium Falciparum DHFR Inhibitors Using A Fragment Linking Strategy
